| アブストラクト | Background and purpose - Smoking is a modifiable risk factor that may adversely affect postoperative outcomes. Healthcare providers are increasingly denying smokers access to total hip and knee arthroplasty (THA and TKA) until they stop smoking. Evidence supporting this is unclear. We assessed the effect of smoking on outcomes following arthroplasty.Patients and methods - We identified THAs and TKAs from the Clinical Practice Research Datalink, which were linked with datasets from Hospital Episode Statistics and the Office for National Statistics to identify outcomes. The effect of smoking on postoperative outcomes (complications, medications, revision, mortality, patient-reported outcome measures [PROMs]) was assessed using adjusted regression models.Results - We studied 60,812 THAs and 56,212 TKAs (11% smokers, 33% ex-smokers, 57% non-smokers). Following THA, smokers had an increased risk of lower respiratory tract infection (LRTI) and myocardial infarction compared with non-smokers and ex-smokers. Following TKA, smokers had an increased risk of LRTI compared with non-smokers. Compared with non-smokers (THA relative risk ratio [RRR] = 0.65; 95% CI = 0.61-0.69; TKA RRR = 0.82; CI = 0.78-0.86) and ex-smokers (THR RRR = 0.90; CI = 0.84-0.95), smokers had increased opioid usage 1-year postoperatively. Similar patterns were observed for weak opioids, paracetamol, and gabapentinoids. 1-year mortality rates were higher in smokers compared with non-smokers (THA hazard ratio [HR] = 0.37, CI = 0.29-0.49; TKA HR = 0.52, CI = 0.34-0.81) and ex-smokers (THA HR = 0.53, CI = 0.40-0.70). Long-term revision rates were not increased in smokers. Smokers had improvement in PROMs compared with preoperatively, with no clinically important difference in postoperative PROMs between smokers, non-smokers, and ex-smokers.Interpretation - Smoking is associated with more medical complications, higher analgesia usage, and increased mortality following arthroplasty. Most adverse outcomes were reduced in ex-smokers, therefore smoking cessation should be encouraged before arthroplasty. |
|---|
| ジャーナル名 | Acta orthopaedica |
|---|
| Pubmed追加日 | 2019/8/3 |
|---|
| 投稿者 | Matharu, Gulraj S; Mouchti, Sofia; Twigg, Sarah; Delmestri, Antonella; Murray, David W; Judge, Andrew; Pandit, Hemant G |
|---|
| 組織名 | Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences,;University of Oxford, Nuffield Orthopaedic Centre, Oxford.;Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical;School, University of Bristol.;Bradford Teaching Hospitals NHS Foundation Trust, St Luke's Hospital, Bradford.;Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton;Hospital and University of Leeds, Leeds.;National Institute for Health Research Bristol Biomedical Research Centre (NIHR;Bristol BRC), University Hospitals Bristol NHS Foundation Trust, University of;Bristol, Southmead Hospital, Bristol, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/31370730/ |
|---|
